We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.06%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.89B
AUM Growth
+$8.03M
Cap. Flow
+$48.2M
Cap. Flow %
1.24%
Top 10 Hldgs %
14.93%
Holding
1,432
New
121
Increased
566
Reduced
530
Closed
107

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$12.2M
2
CSCO icon
Cisco
CSCO
+$6.27M
3
EMR icon
Emerson Electric
EMR
+$5.92M
4
HA
Hawaiian Holdings, Inc.
HA
+$5.41M
5
ACM icon
Aecom
ACM
+$5.1M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$15.8M
2
MET icon
MetLife
MET
+$6.37M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.85M
4
DWX icon
State Street SPDR S&P International Dividend ETF
DWX
+$4.32M
5
PII icon
Polaris
PII
+$4M

Sector Composition

Rank Sector Weight
1 Healthcare 13.29%
2 Financials 11.98%
3 Technology 11.97%
4 Industrials 9.85%
5 Consumer Discretionary 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DBRG icon
1301
DigitalBridge
DBRG
$2.93B
$61K ﹤0.01%
+2,743
New +$89.3K
CCIH
1302
DELISTED
Chinacache International Holdings Ltd
CCIH
$61K ﹤0.01%
57,447
– –
OPK icon
1303
Opko Health
OPK
$985M
$60K ﹤0.01%
18,814
+3,150
+20% +$12.7K
QUIK icon
1304
QuickLogic
QUIK
$232M
$59K ﹤0.01%
2,743
+2,029
+284% +$51.3K
JCP
1305
DELISTED
J.C. Penney Company, Inc.
JCP
$58K ﹤0.01%
19,400
+8,000
+70% +$28.8K
AXAS
1306
DELISTED
Abraxas Petroleum Corp
AXAS
$57K ﹤0.01%
1,275
– –
ATRS
1307
DELISTED
Antares Pharma, Inc.
ATRS
$56K ﹤0.01%
25,600
– –
ANH
1308
DELISTED
Anworth Mortgage Asset Corporation
ANH
$56K ﹤0.01%
11,600
-9,300
-44% -$46K
TCRT icon
1309
Alaunos Therapeutics
TCRT
$4.59M
$51K ﹤0.01%
87
-2
-2% -$1.25K
MIN
1310
Aberdeen Intermediate Income Fund
MIN
$274M
$48K ﹤0.01%
12,200
-4,200
-26% -$16.7K
PDLI
1311
DELISTED
PDL BioPharma, Inc.
PDLI
$45K ﹤0.01%
15,188
+3,700
+32% +$10.1K
SCU
1312
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$43K ﹤0.01%
1,600
-30
-2% -$788
IBRX icon
1313
ImmunityBio
IBRX
$7.51B
$40K ﹤0.01%
10,300
– –
OIG
1314
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$40K ﹤0.01%
388
– –
CGRN
1315
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$36K ﹤0.01%
3,184
+350
+12% +$3.1K
TPST icon
1316
Tempest Therapeutics
TPST
$13.7M
$31K ﹤0.01%
13
-1
-7% -$3K
BNBX
1317
DELISTED
BNB PLUS CORP
BNBX
– –
0
– –
ATHX
1318
DELISTED
Athersys, Inc. Common Stock
ATHX
$18K ﹤0.01%
400
-28
-7% -$1.21K
GSAT icon
1319
Globalstar
GSAT
$10.7B
$10K ﹤0.01%
1,014
– –
TMBR
1320
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$7K ﹤0.01%
2
+1
+100% +$2.96K
NEON icon
1321
Neonode
NEON
$14.1M
$6K ﹤0.01%
1,500
– –
TBCH
1322
Turtle Beach Corp
TBCH
$243M
$6K ﹤0.01%
2,500
– –
C.WS.A
1323
DELISTED
Citigroup Inc
C.WS.A
$2K ﹤0.01%
35,000
– –
AMBA icon
1324
Ambarella
AMBA
$3.77B
– –
-21,498
Closed -$1.26M
AOA icon
1325
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.19B
– –
-10,615
Closed -$572K
51 52
53
54 55

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q1 2018 Portfolio in Review

As of Q1 2018, Oppenheimer & Co held 1,432 positions worth $3.89B, up 0.21% from $3.88B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer & Co's Q1 2018 filing shows 121 new, 566 increased, 530 reduced and 107 closed positions. Its largest new stake was Pricesmart: 38,950 shares worth $3.25M. The largest sale was Meta Platforms (Facebook), an estimated $15.8M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q1 2018 buy was Pricesmart: 38,950 shares worth $3.25M.
  • Oppenheimer & Co added most to Microsoft in Q1 2018, an estimated $12.2M increase.
  • Oppenheimer & Co's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $15.8M.
  • Oppenheimer & Co fully exited Polaris in Q1 2018, selling an estimated $4M.
  • Oppenheimer & Co's ten largest holdings make up 15% of its $3.89B portfolio in Q1 2018.
  • Oppenheimer & Co opened 121 new positions and closed 107 in Q1 2018.
  • Oppenheimer & Co's portfolio value rose 0.21% quarter-over-quarter to $3.89B.

Based on Oppenheimer & Co's 13F filing for Q1 2018, filed 1 May 2018.